Aurobindo Pharma discloses retirement of Mr. N. Ravi Kiran, Chief Business Officer for Emerging Markets, effective April 30, 2026.
The disclosure is made pursuant to Regulation 30 of SEBI Listing Obligations and Disclosure Requirements.
The retirement occurs at close of business hours with no immediate replacement announced in the filing.